Medical Communications

Showing 15 posts of 6411 posts found.

architect_of_the_capitol_2

US “right to try” legislation passes after initial defeat

March 22, 2018 Medical Communications, Research and Development, Sales and Marketing FDA, House of representatives, Right to try, US, pharma

The controversial and much-discussed “right to try” bill has been passed in the US House of Representatives, quickly rebounding after …
brexit_flag_0

Independent committee report seeks Brexit healthcare clarity

March 21, 2018 Medical Communications, Research and Development ABPI, UK, biotech, brexit, drugs, pharma, pharmaceutical

An independent report, entitled Brexit – Medicines, Medical Devices and Substances of Human Origin and written by the Health and …
takeda_global_hq

Takeda completes construction of new global headquarters in Tokyo

March 21, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Japan, Takeda, pharma, tokyo

Japan’s biggest pharmaceutical firm Takeda has announced the completion of construction of its new global headquarters in the country’s capital …
dominic_caruso

J&J’s longest-standing CFO finally steps down

March 21, 2018 Medical Communications, Research and Development J&J, JJ, Johnson & Johnson, biotech, cfo, drugs, pharma, pharmaceutical

Johnson & Johnson have revealed that its Chief Financial Officer and Executive Vice President, Dominic J. Caruso, will retire from …
john_mchutchison

New Chief Science and Medical Officers for Gilead

March 19, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Gilead, appointment

Gilead has announced that Dr Norbert Bischofberger, its Chief Scientific Officer (CSO), Executive Vice President of Research and Development and …

Working Life: Chris Round, Head of EMEA Region, Merck KGaA

March 19, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Chris Round, MSD, Merck, Merck KGaA, Working Life, pharma

Merck KGaA’s Chris Round, Head of EMEA Region, spoke with Pharmafile.com to discuss his time at both the US and …

Pfizer to hang onto CEO, after 61% pay increase

March 19, 2018 Medical Communications, Sales and Marketing Ian Read, Pfizer, biotech, drugs, pharma, pharmaceutical

Pfizer have given its Chief Executive Officer, Ian Read, a big boost to his pay packet, taking it to $27.9 …

Rising levels of opioid prescriptions puts NHS under pressure

March 16, 2018 Medical Communications NHS, biotech, drugs, opioid, pharma, pharmaceutical

It has been found that the number of prescriptions being written for opioid painkillers has risen from 10 million to …

NICE recommends Keytruda via CDF as first and only urothelial carcinoma immunotherapy

March 16, 2018 Medical Communications, Sales and Marketing MSD, NICE, immunotherapy, keytruda, pharma

UK drugs watchdog NICE has published its finance guidance recommending the use of MSD’s Keytruda (pembrolizumab) on the NHS through …

Allergan navigating choppy waters, as shares rise and fall

March 16, 2018 Medical Communications Allergan, Brent Saunders, biotech, drugs, pharma, pharmaceutical

By most measures Allergan has not had the most successful of years and one measure, in particular, is usually indicative …
ears-2545756_960_720

Hearing drug failure puts biotech on brink

March 16, 2018 Medical Communications, Research and Development Auris, biotech, drugs, pharma, pharmaceutical

Biotechs with few products in the portfolio are always at a risk should results come back flat, it often leads …
12_rare

The need for flexible appraisal of rare disease medicines

March 15, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amryt Pharma, feature, pharma, rare disease, rare diseases

Recent data has shown that England is, on average, slower than Germany, France, Spain and Italy in making orphan medicinal …
william_pao

Roche appoints new research and early development head

March 15, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Roche, appointment

Dr John C Reed, Roche’s Head of Pharma Research and Early Development (pRED), is set to leave the company due …

Andrew Witty takes on a new CEO position

March 15, 2018 Medical Communications Andrew Witty, GSK, Optum, UnitedHealth, biotech, drugs, pharma, pharmaceutical

Andrew Witty, who made his name working his way up the ranks at GSK to become its CEO, has revealed …
The Gateway to Local Adoption Series

Latest content